U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Historical CDC.gov Content

CDC Stacks Public Health Publications

CDC is moving a large quantity of selected historical .PDF files to CDC Stacks. Other selected historical content, including HTML pages, can be found at Archive.CDC.gov at https://archive.cdc.gov/.

(1)
(1)
(12)
(629)
(259)
(337)
(630)
(494)
(385)
(371)
(375)
(441)
(366)
(423)
(175)
(429)
(399)
(331)
(577)
(219)
(208)
(192)
(205)
(154)
(90)
(71)
(69)
(24)
(30)
(12)
(12)
(2)
(11)
(4)
(3)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
0 of 50
(4)
(38)
(28)
(1)
(43)
(13)
(3)
(376)
(1)
(28)
(1009)
(319)
(2)
(78)
(22)
(123)
(2)
(8)
(4)
(3)
(23)
(64)
(115)
(39)
(28)
(927)
(4)
(364)
(379)
(1)
(9)
(78)
(4)
(1761)
(302)
(8)
(4)
(1162)
(14)
(163)
(2)
(129)
(70)
(67)
(74)
(36)
0 of 46
(9)
(1)
(9)
(2)
(3)
(1)
(1)
(2)
(1)
(1)
(1)
(4)
(2)
(1)
(2)
(1)
(1)
(2)
(2)
(30)
(2)
(1)
(1)
(1)
(2)
(9)
(1)
(1)
(173)
(1)
(1)
(1)
(2)
0 of 33
(54)
(9)
(5)
(66)
(14)
(3)
(3)
(6)
(1)
(2)
(1)
(2)
(4)
(173)
(1752)
(1711)
(813)
(894)
(9)
(79)
(627)
(84)
(5)
(5)
(1)
(21)
(32)
(1305)
(61)
(213)
0 of 30
(54)
(24)
(4)
(38)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(98)
(4)
(9)
(1)
(9)
(2)
(2)
(1)
(3)
(3)
(144)
(7)
(162)
(533)
(17)
(24)
(10)
(2)
(910)
(1660)
(4)
(37)
(250)
(35)
(97)
(272)
(123)
(3)
(23)
(10)
(166)
(1)
(450)
(99)
(176)
(2)
(14)
(16)
(8)
(38)
(3)
(25)
(28)
(21)
(553)
(1)
(3)
(1)
(1305)
(2)
(52)
(2)
(141)
(70)
0 of 65
(4)
(2)
(1)
(8)
(39)
(31)
(1)
(1)
(34)
(9)
(13)
(158)
(3)
(23)
(14)
(1)
(7)
(1)
(10)
(3)
(4)
(6)
(3)
(1)
(4)
(2)
(2)
(1)
(2)
(1)
(69)
(8)
(34)
(28)
(11)
(4)
(1)
(7)
(9)
(2)
0 of 40
(13)
(31)
(4)
(2)
(6)
(5)
(13)
(6870)
(12)
0 of 9
(1)
(8)
(1)
(1)
(8)
(1)
(1)
0 of 7
(3)
(7)
(1)
(1)
(11)
(2)
(11)
(1)
(1)
(1)
(3)
(1)
(1)
(7)
(1)
(11)
(1)
(3)
(1)
(1)
(1)
(1)
(9)
(1)
(2)
(1)
(1)
(7)
(2)
(4)
(2)
(3)
(2)
(1)
(1)
(2)
(25)
(1)
(23)
(1)
(1)
(9)
(1)
(1)
(2)
(1)
(5)
(2)
(4)
(2)
(7)
(2)
(1)
(22)
(1)
(25)
(2)
(1)
(2)
(4)
(1)
(1)
(2)
(1)
(15)
(1)
(1)
(6)
(1)
(2)
(1)
(16)
(2)
(2)
(2)
(14)
(2)
(1)
(23)
(19)
(9)
(11)
(3)
(1)
(2)
(2)
(1)
(11)
(7)
(16)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(5)
(2)
(1)
(1)
(2)
(5)
(1)
(1)
(2)
(2)
(1)
(1)
(152)
(12)
(3)
(1)
(3)
(18)
(18)
(1)
(2)
(16)
(2)
(1)
(1)
(10)
(7)
(5)
(1)
(1)
(1)
(7)
(1)
(23)
(4)
(9)
(4)
(1)
(9)
(1)
(1)
(1)
(4)
(1)
(1)
(2)
(4)
(2)
(2)
(10)
(10)
(2)
(1)
(3)
(20)
(5)
(1)
(1)
(4)
(14)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(14)
(1)
(1)
(1)
(2)
(1)
(1)
(39)
(1)
(3)
(1)
(3)
(7)
(1)
(1)
(4)
(2)
(2)
(2)
(6)
(1)
(1)
(1)
(1)
(2)
(2)
(2)
(2)
(6)
(2)
(2)
(1)
(1)
(1)
(1)
(1)
(10)
(2)
(2)
(2)
(2)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(6)
(6)
(1)
(5)
(2)
(12)
(1)
(11)
(1)
(1)
(1)
(1)
(1)
(5)
(3)
(1)
(11)
(13)
(2)
(1)
(13)
(2)
(1)
(2)
(2)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(7)
(2)
(8)
(1)
(1)
(1)
(1)
(2)
(9)
(5)
(1)
(2)
(1)
(3)
(1)
(1)
(2)
(1)
(1)
(2)
(10)
(2)
(2)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(3)
(2)
(23)
(1)
(3)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(6)
(2)
(1)
(11)
(2)
(2)
(2)
(1)
(2)
(1)
(1)
(1)
(6)
(31)
(4)
(7)
(1)
(28)
(2)
(7)
(4)
(2)
(13)
(4)
(5)
(1)
(9)
(1)
(1)
(1)
(1)
(14)
(1)
(2)
(6)
(3)
(2)
(2)
(5)
(15)
(1)
(3)
(1)
(4)
(1)
(23)
(1)
(3)
(1)
(1)
(7)
(1)
(2)
(2)
(1)
(6)
(7)
(2)
(1)
(1)
(2)
(15)
(3)
(7)
(4)
(1)
(1)
(6)
(2)
(1)
(1)
(21)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(2)
(3)
(7)
(26)
(7)
(3)
(17)
(1)
(1)
(1)
(1)
(15)
(1)
(7)
(6)
(1)
(3)
(1)
(1)
(2)
(1)
(5)
(9)
(5)
(5)
(7)
(2)
(2)
(1)
(4)
0 of 402
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(4)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(5)
(1)
(3)
(1)
(1)
(2)
(1)
(2)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
0 of 90
(1)
(1)
(1)
(1)
(1)
(9)
(1)
(2)
(4)
(15)
(1)
(1)
(40)
(3)
(1)
(8)
(1)
(80)
(1)
(3)
(3)
(13)
(1)
(1)
(147)
(1)
(1)
(6)
(2)
(5)
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
(1)
(2)
(2)
(1)
(2)
(1)
(2)
(3)
(1)
(8)
(23)
(2)
(1)
(1)
(1)
(1)
(1)
(9)
(2)
(4)
(1)
(1)
(1)
(43)
(2)
(3)
(1)
(4)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(25)
(4)
(4)
(1)
(1)
(1)
(1)
(1)
(2)
(1)
(1)
0 of 88
(1)
(1)
(1)
(18)
(14)
(1)
(4)
(1)
(62)
(11)
(2)
(10)
(4)
(1)
(1)
(21)
(4)
(2)
(1)
(9)
(2)
(1)
(40)
(1)
(9)
(2)
(9)
(1)
(1)
(38)
(1)
(18)
(5)
(4)
(18)
0 of 35
(11)
(9)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(9)
(2)
(1)
(2)
(2)
(1)
(6)
(1)
(1)
(2)
(4)
(1)
(1)
(1)
(3)
(1)
(1)
(1)
(1)
(1)
(3)
(1)
(1)
(2)
(2)
(1)
(1)
(1)
(1)
0 of 40
(1)
(1)
0 of 2
Showing 741 - 760 of 7962 results
  • A road map for efficient and reliable human genome epidemiology
    A road map for efficient and reliable human genome epidemiology
    01/01/2006 | NCBDDD
    Commentary co-authored by the Public Health Genomics Branch. Given the complexity and limitations of genetic testing for risk of breast and ovarian cancer, the development and broad dissemination of clinical guidelines and education of physicians are needed.
    Public Domain
  • ABA EPT 2008
    ABA: EPT 2008
    05/01/2025 | NCHHSTP
    Legality of EPT
    Public Domain
  • ACCAHAAAPAABCACPMAGSAPhAASHASPCNMAPCNA Guideline for the Prevention Detection Evaluation and Management of High Blood Pressure in Adults
    ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
    06/01/2018 | NCCDPHP
    high blood pressure, blood pressure management, prevention
    Public Domain
  • ACCLPP Summary Statement
    ACCLPP Summary Statement
    01/04/2012 | NCEH
    Summary statement of the Advisory Committee Childhood Lead Poisoning Prevention (ACCLPP) call on January 4, 2012, to make recommendations to CDC regarding changing the blood lead level of concern.
    Public Domain
  • ACH Royalty Payment Enrollment Form
    ACH Royalty Payment Enrollment Form
    08/01/2013 | OADS
    Form
    Public Domain
  • ACIP Resolution No 02131
    ACIP Resolution No. 02/13-1
    02/20/2013 | NCIRD
    The purpose of this resolution is to update recommendations regarding the use of this vaccine in PCV13-naïve children aged 6-18 years.
    Public Domain
  • ACIP Resolution No 02131
    ACIP Resolution No. 02/13-1
    02/20/2013 | NCIRD
    The purpose of this resolution is to update recommendations regarding the use of this vaccine in PCV13-naïve children aged 6-18 years
    Public Domain
  • ACIP Resolution No 02152
    ACIP Resolution No. 02/15-2
    02/26/2015 | NCIRD
    The purpose of this resolution is to update the resolution to include use of a 9-valent HPV vaccine that was recently licensed for use and to clarify the schedule and timing of vaccine intervals
    Public Domain
  • ACIP Resolution No 06091
    ACIP Resolution No. 06/09-1
    06/24/2009 | NCIRD
    The purpose of this resolution is to update the minimum dosage interval for inactivated polio vaccine and to streamline the resolution through the use of links to published documents.
    Public Domain
  • ACIP Resolution No 10032
    ACIP Resolution No. 10/03-2
    10/16/2003 | NCIRD
    The purpose of this resolution is to correct unintentional inconsistencies between VFC Resolution (02/03-1) and current ACIP recommendations for the use of hepatitis B vaccines.
    Public Domain
  • ACIP Resolution No 10121
    ACIP Resolution No. 10/12-1
    10/24/2012 | NCIRD
    The purpose of this resolution is to revise the previous resolution to incorporate new recommendations regarding the vaccination of pregnant adolescents.
    Public Domain
  • ACIP Resolution No 10162
    ACIP Resolution No. 10/16-2
    10/19/2016 | NCIRD
    The purpose of this resolution is to reflect the new dosing schedules for human papillomavirus vaccine.
    Public Domain
  • ACIP Resolution No 10163
    ACIP Resolution No. 10/16-3
    10/19/2016 | NCIRD
    The purpose of this revision is to update the recommended vaccination schedule and intervals for Trumenba®, one of the sergroup B vaccines covered by the resolution.
    Public Domain
  • ACIP Resolution No 10173
    ACIP Resolution No. 10/17-3
    10/25/2017 | NCIRD
    The purpose of this resolution is to update guidance on the use of mumps-containing vaccine in the context of a mumps outbreak and to update links to published documents.
    Public Domain
  • ACIP Resolution No 2132
    ACIP Resolution No. 2/13-2
    02/21/2013 | NCIRD
    The purpose of this resolution is to update the list of Hib-containing vaccines that can be used to prevent Hib disease, to correct the catch up recommendations, and to add information about use of Hib-containing vaccines in special populations.
    Public Domain
  • ACIP Resolution No 2171
    ACIP Resolution No. 2/17-1
    02/22/2017 | NCIRD
    The purpose of this resolution is to clarify guidance related to dosing intervals and revaccination.
    Public Domain
  • ACIP Resolution No 2181
    ACIP Resolution No. 2/18-1
    02/21/2018 | NCIRD
    The purpose of this resolution is to add live attenuated influenza vaccine (LAIV) to the VFC program.
    Public Domain
  • ACIP Resolution No 6061
    ACIP Resolution No. 6/06-1
    06/29/2006 | NCIRD
    The purpose of this resolution is to update VFC resolution 2/06-1 pertaining to the vaccines included in the VFC program.
    Public Domain
  • ACIP Resolution No 6081
    ACIP Resolution No. 6/08-1
    06/25/2008 | NCIRD
    The purpose of this resolution is to add a newly licensed rotavirus vaccine to the Vaccines for Children Program.
    Public Domain
  • ACIP Resolution No 69416
    ACIP Resolution No. 6/94-16
    06/29/1994 | NCIRD
    The ACIP has established a schedule for immunization of children 0-18 years eligible to be covered by the VFC program. This schedule applies to routine circumstances. However, during emergencies, such as outbreaks, other children who qualify for the VFC program will need vaccines.
    Public Domain
741 - 760 / 7962